Vir Biotechnology (VIR) has advanced its oncology program by dosing the first patient in a Phase 1 expansion cohort for VIR-5500 in metastatic prostate cancer, following encouraging early safety and ...

As part of the collaboration, Mayo Clinic also agreed to purchase 7.51 million shares of Sana for $3.33 apiece for gross proceeds of about $25 million, according to a filing with the Securities and ...

Nautilus Biotechnology Inc. (NASDAQ:NAUT) is one of the 8 Best Life Sciences Penny Stocks to Buy. On March 18, Nautilus ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy according to hedge funds. On March 16 ...

Biotech ETFs offer diversified exposure to the sector, reducing investment risk. Investing in top biotech ETFs can be cost-effective due to their low expense ratios. Large biotech ETFs provide better ...

Iovance Biotherapeutics argues that there is a meaningful opportunity here of more than 8,000 patients diagnosed annually in ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and improving earnings. The problem: mid-single-digit gains still lagged tech, ...

This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...

Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Focused on infectious disease therapies, this biotech firm reported a notable insider sale amid a year of strong share price gains.